United States Insulin Drugs And Delivery Devices Market Share

Statistics for the 2023 & 2024 United States Insulin Drugs And Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. United States Insulin Drugs And Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of United States Insulin Drugs And Delivery Devices Industry

The United States Insulin Drugs and Delivery Devices Market is consolidated, with few significant and generic players. Recently, mergers and acquisitions between the players have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

US Insulin Drugs & Delivery Devices Market Leaders

  1. Novo Nordisk

  2. Medtronics

  3. Sanofi

  4. Eli Lily

  5. Ypsomped

*Disclaimer: Major Players sorted in no particular order

United States Insulin Drugs And Delivery Devices Market Concentration

US Insulin Drugs & Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)